FBLG FibroBiologics, Inc. - Common Stock
$1,04
Fiyat · May 20, 2026
Temel veriler itibarıyla Nis 30, 2026
52 Haftlık Aralık
$0–$5
16% of range
Analist Derecelendirmesi
BUY
9 analysts
Fiyat Hedefi
$14
+1198% upside
P/E (TTM)
-0.5
ROE
—
Net Kâr Marjı
—
FBLG Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.04
Piyasa Değeri
—
P/E (TTM)
-0.5
EPS (TTM)
$-0.42
Gelir (TTM)
—
Temettü Verimi
—
ROE
—
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$0 – $5
FBLG Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
—
Hisse Başına Kâr
$-0.42
2022-12-31
→
2025-12-31
Serbest Nakit Akışı
—
2023-12-31
→
2024-12-31
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
FBLG
Akran Ortalaması
P/E (TTM)
-0.5
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
FBLG
Akran Ortalaması
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
FBLG
Akran Ortalaması
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
FBLG
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
FBLG
Akran Ortalaması
FBLG Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
9 analist
- Güçlü Al 2 22,2%
- Al 5 55,6%
- Tut 2 22,2%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
2 analist · 2026-05-20
Medyan
$13.50
← Tüm hedeflerin altında
$1.04
Düşük
$8.00
Yüksek
$19.00
Medyan hedef
$13.50
+1198,1%
Ortalama hedef
$13.50
+1198,1%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.02%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-1.33 | $-1.33 | -0.00% |
| 31 Aralık 2025 | $-0.60 | $-1.78 | 1.2% |
| 30 Eylül 2025 | $-2.60 | $-2.19 | -0.41% |
| 30 Haziran 2025 | $-2.40 | $-2.29 | -0.10% |
| 31 Mart 2025 | $-2.80 | $-2.24 | -0.56% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| FBLG | — | -0.5 | — | — | — | — |
| RNAZ | — | -0.1 | — | — | — | — |
| APVO | $9M | -0.1 | — | — | -217.2% | — |
| SNGX | $14M | -0.6 | -85.8% | — | -311.2% | — |
| AQB | $4M | -0.2 | -21.2% | — | -315.5% | — |
| DRMA | — | — | — | — | — | — |
| MBIO | — | -2.5 | — | — | -30.9% | — |
| ENSC | $4M | -0.2 | -2.8% | -200.9% | -294.0% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| R&D Expense | $7M | $5M | $2M | $1M | |
| SG&A Expense | $9M | $9M | $7M | $3M | |
| Operating Expenses | $17M | $14M | $9M | $4M | |
| Operating Income | $-17M | $-14M | $-9M | $-4M | |
| Interest Expense | · | · | $147.0K | $654.0K | |
| Interest Income | $247.0K | $251.0K | · | · | |
| Other Non-op | $-619.0K | $32.0K | $-213.0K | · | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-19M | $-11M | $-16M | $-5M | |
| EPS (Basic) | $-0.42 | $-0.34 | $-0.68 | $-0.18 | |
| EPS (Diluted) | $-0.42 | $-0.34 | $-0.68 | $-0.18 | |
| Shares (Basic) | 44,660,518 | 32,875,075 | 28,230,842 | 28,230,842 | |
| Shares (Diluted) | 44,660,518 | 32,875,075 | 28,230,842 | 28,230,842 | |
| EBITDA | · | $-14M | $-9M | · |
Bilanço 19
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $14M | $9M | $2M | |
| Receivables | · | · | · | $300.0K | |
| Prepaid Expense | $1M | $225.0K | $36.0K | $29.0K | |
| Other Current Assets | $0 | $18.0K | $16.0K | $30.0K | |
| Current Assets | $6M | $14M | $9M | $3M | |
| PP&E (Net) | $842.0K | $824.0K | $797.0K | · | |
| PP&E (Gross) | $1M | $1M | $844.0K | · | |
| Accum. Depreciation | $448.0K | $204.0K | $47.0K | · | |
| Total Assets | $10M | $16M | $12M | $5M | |
| Accounts Payable | $945.0K | $3M | $1M | $758.0K | |
| Short-term Debt | $0 | $9M | · | · | |
| Current Liabilities | $2M | $13M | $9M | $7M | |
| Capital Leases | $2M | $984.0K | $1M | $2M | |
| Total Liabilities | $3M | $14M | $11M | $9M | |
| Common Stock | $1.0K | $0 | · | · | |
| Paid-in Capital | $60M | $38M | $26M | $2M | |
| Retained Earnings | $-54M | $-36M | $-24M | $-8M | |
| Stockholders' Equity | $6M | $3M | $1M | $-4M | |
| Liabilities + Equity | $10M | $16M | $12M | $5M |
Nakit Akışı 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $2M | $265.0K | |
| Operating Cash Flow | $-16M | $-12M | $-6M | $-4M | |
| CapEx | $262.0K | $184.0K | $495.0K | · | |
| Investing Cash Flow | $-262.0K | $-184.0K | $-495.0K | · | |
| Stock Issued | $7M | $8M | · | · | |
| Net Stock Activity | · | $8M | · | · | |
| Financing Cash Flow | $8M | $17M | $14M | $6M | |
| Net Change in Cash | $-9M | $5M | $7M | $2M | |
| Taxes Paid | $0 | $0 | · | · | |
| Free Cash Flow | · | $-12M | $-7M | · |
Kârlılık 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | · | -79.0% | -198.1% | · | |
| ROE | · | -407.9% | -279.6% | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | · | 1.1 | 1.0 | · | |
| Quick Ratio | · | 1.1 | 1.0 | · | |
| Interest Coverage | · | · | -60.5 | · |
Değerleme (TTM) 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-19M | $-11M | $-16M | · | |
| P/E | -0.5 | -5.9 | · | · | |
| Earnings Yield | -186.7% | -17.0% | · | · |
Gelir Tablosu 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $797.0K | $3M | $2M | $2M | $1M | $1M | $975.0K | $960.0K | $772.0K | $547.0K | $478.0K | |
| SG&A Expense | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $5M | $3M | $5M | $4M | $5M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Operating Income | $-5M | $-3M | $-5M | $-4M | $-5M | $-4M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | |
| Interest Expense | · | · | · | · | · | · | · | $5.0K | $4.0K | · | $10.0K | $135.0K | |
| Interest Income | $20.0K | $25.0K | $73.0K | $50.0K | $99.0K | $63.0K | $79.0K | $70.0K | $39.0K | · | · | · | |
| Other Non-op | $-2.0K | $6.0K | $0 | · | $0 | $1.0K | $2.0K | $30.0K | · | $0 | $-57.0K | $-15.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Net Income | $-5M | $-3M | $-6M | $-5M | $-5M | $-3M | $-500.0K | $898.0K | $-8M | $-10M | $-2M | $-2M | |
| EPS (Basic) | $-1.33 | $-0.03 | $-0.13 | $-0.12 | $-2.71 | $-0.09 | $-0.01 | $0.03 | $-0.27 | $-0.34 | $-0.08 | $-0.18 | |
| EPS (Diluted) | $-1.33 | $-0.03 | $-0.13 | $-0.12 | $-2.71 | $-0.09 | $-0.01 | $0.03 | $-0.27 | $-0.34 | $-0.08 | $-0.18 | |
| Shares (Basic) | 3,772,930 | -73,720,414 | 43,072,542 | 38,635,264 | 1,833,656 | -64,494,468 | 33,516,656 | 32,719,125 | 31,133,762 | -56,461,684 | 28,230,842 | 28,230,842 | |
| Shares (Diluted) | 3,772,930 | -73,720,414 | 43,072,542 | 38,635,264 | 1,833,656 | -64,494,468 | 33,516,656 | 32,719,125 | 31,133,762 | -56,461,684 | 28,230,842 | 28,230,842 | |
| EBITDA | $-5M | · | $-5M | $-4M | $-5M | · | $-3M | $-3M | $-3M | · | · | · |
Bilanço 19
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $5M | $5M | $9M | $9M | $14M | $8M | $6M | $8M | $9M | · | · | |
| Prepaid Expense | $1M | $1M | $373.0K | $1M | $642.0K | $225.0K | $353.0K | $518.0K | $746.0K | $36.0K | · | · | |
| Other Current Assets | $403.0K | $0 | · | · | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $16.0K | · | · | |
| Current Assets | $3M | $6M | $5M | $10M | $9M | $14M | $8M | $7M | $9M | $9M | · | · | |
| PP&E (Net) | $776.0K | $842.0K | $908.0K | $967.0K | $814.0K | $824.0K | $772.0K | $799.0K | $770.0K | $797.0K | · | · | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $1M | $1M | $929.0K | $918.0K | $852.0K | $844.0K | · | · | |
| Accum. Depreciation | $514.0K | $448.0K | $382.0K | $317.0K | $257.0K | $204.0K | $157.0K | $119.0K | $82.0K | $47.0K | · | · | |
| Total Assets | $6M | $10M | $9M | $14M | $11M | $16M | $10M | $9M | $11M | $12M | · | · | |
| Accounts Payable | $850.0K | $945.0K | $1M | $2M | $1M | $3M | $1M | $1M | $814.0K | $1M | · | · | |
| Short-term Debt | · | $0 | $5M | $8M | $6M | $9M | $115.0K | $287.0K | $459.0K | · | · | · | |
| Current Liabilities | $2M | $2M | $7M | $11M | $8M | $13M | $7M | $10M | $14M | $9M | · | · | |
| Capital Leases | $2M | $2M | $2M | $2M | $865.0K | $984.0K | $1M | $1M | $1M | $1M | · | · | |
| Total Liabilities | $3M | $3M | $9M | $13M | $9M | $14M | $8M | $11M | $15M | $11M | · | · | |
| Total Debt | · | · | $5M | $8M | $6M | · | $115.0K | $287.0K | $459.0K | · | · | · | |
| Common Stock | $1.0K | $1.0K | $0 | $0 | · | $0 | · | · | · | · | · | · | |
| Paid-in Capital | $62M | $60M | $51M | $46M | $43M | $38M | $35M | $30M | $29M | $26M | · | · | |
| Retained Earnings | $-59M | $-54M | $-51M | $-45M | $-40M | $-36M | $-32M | $-32M | $-33M | $-24M | · | · | |
| Stockholders' Equity | $3M | $6M | $125.0K | $860.0K | $2M | $3M | $3M | $-2M | $-4M | $1M | · | · | |
| Liabilities + Equity | $6M | $10M | $9M | $14M | $11M | $16M | $10M | $9M | $11M | $12M | · | · |
Nakit Akışı 10
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $694.0K | $702.0K | $704.0K | $729.0K | $551.0K | $544.0K | $572.0K | $578.0K | $525.0K | $432.0K | $448.0K | $448.0K | |
| Operating Cash Flow | $-4M | $-3M | $-4M | $-4M | $-5M | $-3M | $-3M | $-2M | $-4M | $-2M | $-2M | $-2M | |
| CapEx | $0 | $0 | $6.0K | $213.0K | $43.0K | $99.0K | $11.0K | $66.0K | $8.0K | $2.0K | $24.0K | $56.0K | |
| Investing Cash Flow | $0 | $0 | $-6.0K | $-213.0K | $-43.0K | $-99.0K | $-11.0K | $-66.0K | $-8.0K | $-2.0K | $-24.0K | $-56.0K | |
| Stock Issued | $706.0K | · | · | · | $0 | $45.0K | $5M | $0 | $3M | · | · | · | |
| Net Stock Activity | $706.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $952.0K | $3M | $0 | $4M | $0 | $9M | $4M | $-172.0K | $3M | $0 | $-2M | $15M | |
| Net Change in Cash | $-3M | $27.0K | $-4M | $178.0K | $-5M | $6M | $2M | $-2M | $-1M | $-2M | $-3M | $12M | |
| Taxes Paid | $0 | · | · | · | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | $-4M | · | · | · | $-5M | · | · | · | $-4M | · | · | · |
Kârlılık 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -57.6% | · | -60.2% | -40.8% | -43.5% | · | -9.6% | 20.2% | -148.4% | · | · | · | |
| ROE | -202.0% | · | -403.8% | 610.1% | 656.4% | · | -36.5% | -75.2% | 438.0% | · | · | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | · | 0.8 | 0.9 | 1.1 | · | 1.2 | 0.6 | 0.6 | · | · | · | |
| Quick Ratio | 0.8 | · | 0.7 | 0.8 | 1.1 | · | 1.2 | 0.6 | 0.6 | · | · | · | |
| Debt / Equity | · | · | 36.6 | 9.4 | 2.5 | · | 0.0 | -0.1 | -0.1 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | -644.8 | -862.5 | · | · | · |
Değerleme (TTM) 3
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-20M | · | $-16M | $-9M | $-13M | · | $-10M | $-12M | $-15M | · | · | · | |
| P/E | -0.3 | · | -1.4 | -2.6 | -2.3 | · | -9.4 | -12.5 | -17.7 | · | · | · | |
| Earnings Yield | -325.0% | · | -73.3% | -38.6% | -43.3% | · | -10.7% | -8.0% | -5.6% | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Net Gelir | $-19M | $-11M | $-16M | $-5M |
| Seyreltilmiş Hisse Başı Kâr | $-0.42 | $-0.34 | $-0.68 | $-0.18 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Cari Oran | — | 1.1 | 1.0 | — |
| Cari Oran | — | 1.1 | 1.0 | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Serbest Nakit Akışı | — | $-12M | $-7M | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.